The Bhardwaj Laboratory conducts research in the following areas:
- Neoantigens in Myeloproliferative neoplasms (MPNs) – Cansu Cimen Bozkus PhD
- Natural Killer (NK) cell dysfunction in human malignancies – Adam Farkas PhD
- Myeloid cell-mediated resistance to immune checkpoint blockade – Michelle Tran
- Adaptive immune responses to mutated tumor antigens – Jenna Newman PhD
- Human dendritic cell subsets in steady-state & infection – Sreekumar Balan PhD
- Effector cell dysfunction in HPV-related malignancies- Kazuki Sone MD PhD
- Harnessing the dark genome in mRNA cancer vaccination- Ashley Reid
- Leveraging cDC1 populations for enhanced RNA cancer vaccination- Ross Ward PhD